KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2025)

Historic Inventory Average for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to $611.7 million.

  • Amneal Pharmaceuticals' Inventory Average rose 439.34% to $611.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $611.7 million, marking a year-over-year increase of 439.34%. This contributed to the annual value of $596.9 million for FY2024, which is 734.8% up from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Inventory Average of $611.7 million as of Q3 2025, which was up 439.34% from $605.2 million recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Inventory Average peaked at $611.7 million during Q3 2025, and registered a low of $493.8 million during Q1 2021.
  • For the 5-year period, Amneal Pharmaceuticals' Inventory Average averaged around $552.9 million, with its median value being $539.8 million (2023).
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Inventory Average soared by 2058.92% in 2021, and later skyrocketed by 141.48% in 2022.
  • Amneal Pharmaceuticals' Inventory Average (Quarter) stood at $504.8 million in 2021, then increased by 6.43% to $537.3 million in 2022, then grew by 7.75% to $578.9 million in 2023, then grew by 4.4% to $604.4 million in 2024, then rose by 1.21% to $611.7 million in 2025.
  • Its last three reported values are $611.7 million in Q3 2025, $605.2 million for Q2 2025, and $606.9 million during Q1 2025.